These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23528005)

  • 1. Juvenile idiopathic arthritis: an update on current pharmacotherapy and future perspectives.
    Wahezi DM; Ilowite NT
    Expert Opin Pharmacother; 2013 Jun; 14(8):975-89. PubMed ID: 23528005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics in juvenile idiopathic arthritis: a narrative review.
    Vanoni F; Minoia F; Malattia C
    Eur J Pediatr; 2017 Sep; 176(9):1147-1153. PubMed ID: 28725955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.
    Berard RA; Laxer RM
    Expert Opin Biol Ther; 2013 Nov; 13(11):1623-30. PubMed ID: 24070010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile idiopathic arthritis.
    Gowdie PJ; Tse SM
    Pediatr Clin North Am; 2012 Apr; 59(2):301-27. PubMed ID: 22560572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)].
    Bukovac LT; Vidović M; Lamot L; Perica M; Harjacek M;
    Reumatizam; 2013; 60(1):57-66. PubMed ID: 24003687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
    Guzman J; Oen K; Tucker LB; Huber AM; Shiff N; Boire G; Scuccimarri R; Berard R; Tse SM; Morishita K; Stringer E; Johnson N; Levy DM; Duffy KW; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey S; Bruns A; Campillo S; Benseler S; Chédeville G; Schneider R; Yeung R; Duffy CM;
    Ann Rheum Dis; 2015 Oct; 74(10):1854-60. PubMed ID: 24842571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile idiopathic arthritis--current and future therapies.
    Kahn P
    Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel treatment options for juvenile idiopathic arthritis.
    Steigerwald KA; Ilowite NT
    Expert Rev Clin Pharmacol; 2015; 8(5):559-73. PubMed ID: 26294075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategies for juvenile idiopathic arthritis.
    Klein A; Horneff G
    Expert Opin Pharmacother; 2009 Dec; 10(18):3049-60. PubMed ID: 19954274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options.
    Pagnini I; Bertini F; Cimaz R
    Paediatr Drugs; 2016 Apr; 18(2):101-8. PubMed ID: 26939782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile idiopathic arthritis - an update on pharmacotherapy.
    Kahn P
    Bull NYU Hosp Jt Dis; 2011; 69(3):264-76. PubMed ID: 22035441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the treatment of juvenile idiopathic arthritis.
    Harris JG; Kessler EA; Verbsky JW
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):337-46. PubMed ID: 23605168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Juvenile Idiopathic Arthritis: A Clinical Guide.
    Blazina Š; Markelj G; Avramovič MZ; Toplak N; Avčin T
    Paediatr Drugs; 2016 Dec; 18(6):397-412. PubMed ID: 27484749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: a community-based cohort study in Taiwan.
    Shen CC; Yeh KW; Ou LS; Yao TC; Chen LC; Huang JL
    J Microbiol Immunol Infect; 2013 Aug; 46(4):288-94. PubMed ID: 22727543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies.
    Vidqvist KL; Malin M; Varjolahti-Lehtinen T; Korpela MM
    Rheumatology (Oxford); 2013 Nov; 52(11):1999-2003. PubMed ID: 23893666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of biologic treatments on growth in children with juvenile idiopathic arthritis.
    Uettwiller F; Perlbarg J; Pinto G; Bader-Meunier B; Mouy R; Compeyrot-Lacassagne S; Melki I; Wouters C; Prieur AM; Landais P; Polak M; Quartier P
    J Rheumatol; 2014 Jan; 41(1):128-35. PubMed ID: 24293576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosing regimen determination for juvenile idiopathic arthritis: a review of studies during drug development.
    Ji P; Chowdhury BA; Yim S; Sahajwalla CG
    J Pharm Sci; 2012 Aug; 101(8):2621-34. PubMed ID: 22653876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile idiopathic arthritis overview and involvement of the temporomandibular joint: prevalence, systemic therapy.
    Carrasco R
    Oral Maxillofac Surg Clin North Am; 2015 Feb; 27(1):1-10. PubMed ID: 25483440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Juvenile arthritides].
    Horneff G
    Z Rheumatol; 2010 Oct; 69(8):719-35; quiz 736-7. PubMed ID: 20798949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile idiopathic arthritis in the new world of biologics.
    Ostring GT; Singh-Grewal D
    J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.